After earning a bachelor’s degree in information technology from Hodges University, Ray Blanco spent over a decade working for public and private companies as a network technician and systems analyst. Ray used to work for one of the most successful private wealth management firms in the country — with over $30 billion in assets under management — to design and oversee their entire network infrastructure, everything from Internet connectivity to data integrity and security. This experience included technology management for large trading and investment firms. From advanced robotics and avionics… to genomics and biotechnology… Ray is an expert. Combining his passion for technology with his financial and stock market expertise, he joined the team in 2009. He is the editor of Technology Profits Confidential, FDA Trader, Penny Pot Profits and Breakthrough Technology Alert and is the lead contributor to Technology Profits Daily.
2019 is the year of the satellite and it means big things for your bank account. Plus, we’re introducing Ray’s Cannabis Corner. A special section of Technology Profits Daily specifically dedicated to cannabis.
2018 has been a wild ride, full of opportunity. Ray takes a look back on some of our best plays from over the past year. Plus, he gives updates on the future of the sector, and what we have to look forward to.
Shares are under pressure today, as short sellers get excited about the prospect of a drop. At this point, it's unclear who's right – Aphira or the short sellers. But we are not sticking around to find out the answer.
Ray reveals that a new way to connect to the internet is getting ready to blast off. Plus, the biotech world has been roiled by developments overseas
For cannabis investors who've ignored the noise and simply ridden the trend higher, the results have been unbelievably lucrative. This is the definition of a "buy-the-dips market." And we're currently in the middle of a dip. That means a major buying opportunity is around the corner!
As we head into the end of the calendar year, we can look forward to more biotech success in 2019. Ray has analysis and some great examples...